Shed vs Maximus: Coaching and Name-Brand vs Compounded
Shed vs Maximus is a choice between a coaching-focused platform that offers both name-brand and compounded GLP-1 medications and a low-cost, compounded-only telemedicine provider. Early verdict: choose Shed if you want integrated coaching and a choice of name-brand or compounded options; choose Maximus if your priority is a low flat compounded price at $132.99/month.
Start Shed’s 2-minute assessment
Quick comparison highlights: price, medication options, coaching, and access
This comparison uses only supplied facts. It contrasts Shed and Maximus across the most distinctive differences: pricing structure, medication types offered, coaching and program model, telemedicine access and approval speed, and regulatory notes and outcome claims.
Pricing and payment model
Shed: Offers compounded semaglutide starting at $199/month and compounded tirzepatide starting at $299/month. New patients may receive 10% off the first month. Shed does not publish a single standard price for all users; you receive a personalized quote after intake.
See Maximus pricing and sign up
Maximus: Advertises a low flat rate at $132.99/month for compounded semaglutide. The direct-pay model is presented as straightforward and transparent with no membership fees noted in the supplied material.
Medication options and flexibility
Shed: Offers both FDA-approved name-brand GLP-1 medications and compounded alternatives on one platform, letting patients choose based on budget and preference. The source explicitly notes name-brand options provide regulatory assurance at a higher cost while compounded options are more affordable.
Maximus: Offers compounded semaglutide only, filled through trusted U.S. pharmacies according to the supplied description. The provider does not list name-brand options in the supplied evidence.
Coaching and program model
Shed: Integrates continuous coaching into treatment rather than issuing a prescription only. The platform markets coaching as supporting titration, lifestyle changes, and plateaus throughout the program. The supplied evidence describes coaching as bundled into the monthly cost.
Maximus: Described as a simple, no-frills telemedicine program focusing on affordable, direct-pay access. The supplied material emphasizes convenient telemedicine access and licensed doctor approvals but does not describe integrated ongoing coaching.
Explore Shed membership and coaching
Access, approval speed, and logistics
Shed: Uses a 2-minute online assessment to check eligibility; a licensed provider reviews the case and issues prescriptions only if treatment is medically appropriate. Medication is shipped to the home and coaching begins with the plan. Pricing beyond starting amounts is provided after intake.
Maximus: Provides telemedicine access with prescriptions approved by licensed doctors and filled by U.S. pharmacies. The process requires no clinic visits. The supplied material notes availability in all 50 states except Mississippi for the named Weight Loss Protocol and indicates free expedited shipping in captured landing-page text.
Regulatory note and outcome statements
Both providers include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality; Shed notes this when describing its compounded offerings and name-brand distinction, and Maximus notes compounded medication status in its descriptions.
On outcomes, the supplied evidence cites clinical trial averages: Shed references Wegovy clinical-trial averages for context and notes results may vary; Maximus cites a 14.9% average weight loss figure from semaglutide studies and other study-linked outcome statements in its captured content. These are presented as sourced claims in the provided materials, not guarantees of individual results.
Side-by-side comparison table
| Criteria | Shed | Maximus |
|---|---|---|
| Starting price | Compounded semaglutide starting at $199/month; compounded tirzepatide starting at $299/month; 10% off first month | Flat rate at $132.99/month for compounded semaglutide |
| Medication types | Name-brand and compounded GLP-1 options | Compounded semaglutide only |
| Coaching | Continuous coaching integrated into treatment | No integrated coaching described in supplied evidence |
| Access and approval | 2-minute assessment then clinician review; prescriptions only if medically appropriate | Telemedicine with licensed doctors; no clinic visits required; refunds if not approved noted in captured content |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
How to choose between Shed and Maximus
Choose Shed if you want an integrated coaching program and the option to select name-brand or compounded GLP-1, understand coaching is bundled into cost, and value a quick online assessment followed by clinician review.
Start Shed and compare medication options
Choose Maximus if your priority is a lower flat monthly price for compounded semaglutide at $132.99/month, simple telemedicine access with prescriptions approved by licensed doctors, and domestic pharmacy fulfillment as described in the supplied content.
Final note: This comparison is based only on the supplied materials. For personalized medical advice, consult a licensed provider. Shed vs Maximus highlights a tradeoff between broader medication choice plus coaching and a lower-cost compounded-only model.